Q1 EPS Estimates for Vera Therapeutics Boosted by Wedbush
Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) – Analysts at Wedbush raised their Q1 2025 earnings estimates for Vera Therapeutics in a research note issued to investors on Thursday, February 27th. Wedbush analyst L. Chico now forecasts that the company will earn ($0.72) per share for the quarter, up from their previous estimate of ($0.81). […]
